Congenital Aplasia Of The Vas Deferens

Congenital Aplasia of the Vas Deferens (CAVD) is a rare condition characterized by the absence or underdevelopment of the vas deferens, the tubes responsible for carrying sperm from the testicles to the urethra. This condition is a significant cause of male infertility, as the absence of the vas deferens prevents the normal transport of sperm. CAVD can occur as an isolated condition or as part of a more complex syndrome, such as Cystic Fibrosis (CF).

Etiology

The primary cause of Congenital Aplasia of the Vas Deferens is genetic mutations. The most common association is with mutations in the CFTR gene, the same gene responsible for Cystic Fibrosis. While not all individuals with CAVD have CF, a significant proportion have at least one mutated CFTR gene, indicating a genetic link between the two conditions. Environmental factors have not been strongly linked to the development of CAVD.

Pathophysiology

In CAVD, the vas deferens fails to develop properly during fetal development. This can be due to mutations in the CFTR gene affecting the embryological development of the vas deferens. The CFTR protein plays a role in the movement of chloride ions across cell membranes, which is crucial for the development and function of several organs, including the vas deferens.

Clinical Presentation

Men with CAVD typically present with symptoms of infertility. Physical examination may reveal the absence of the vas deferens, which is usually palpable in the scrotum. Other symptoms may include low volume of ejaculate. It's important to note that sexual function is not affected by CAVD.

Diagnosis

Diagnosis of CAVD involves a combination of physical examination, semen analysis, and genetic testing. The absence of the vas deferens can be confirmed through physical examination. Semen analysis typically shows low volume, low pH, and absence of sperm (azoospermia). Genetic testing for mutations in the CFTR gene can help confirm the diagnosis and assess the risk of Cystic Fibrosis in offspring.

Treatment

Treatment for CAVD focuses on addressing infertility. Assisted reproductive technologies, such as In Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI), are often used. In this process, sperm are directly extracted from the testicles or epididymis and injected into an egg in the laboratory. This method bypasses the need for the vas deferens by directly fertilizing the egg with the sperm.

Prognosis

The prognosis for individuals with CAVD is generally good, especially with the availability of assisted reproductive technologies for those who wish to have children. However, it is important for individuals with CAVD, especially those with mutations in the CFTR gene, to undergo genetic counseling to understand the implications for offspring, including the risk of Cystic Fibrosis.

See Also

• Male Infertility
• Cystic Fibrosis
• In Vitro Fertilization
• Intracytoplasmic Sperm Injection

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian